Bradley v. ARIAD Pharms., Inc.

(United States First Circuit) – In an investor suit against the company and four corporate officers, following a drop in the share price of the company, alleging securities fraud in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (Exchange Act), 15 U.S.C. sections 78j(b) and 78t(a), as well as the Securities and Exchange Commission’s (SEC) Rule 10b-5, 17 C.F.R. section 240.10b-5, the district court’s judgment is: 1) affirmed as to the dismissal of the securities fraud counts, except with respect to one particular alleged misstatement for which we find the allegations set forth in the complaint sufficient to state a claim; and 2) affirmed as to the disposition of the plaintiffs’ claims under Sections 11 and 15, albeit on different grounds than those articulated by the district court.